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C. elegansIn many organisms early embryogenesis is characterised by a period refractory to transcription. In
Caenorhabditis elegans, the one-cell embryo is transcriptionally inactive, but at around eight-cell stage
transcription is activated in the somatic lineage. This model suggests that histone tail modiﬁcations associated
with activation of transcription, such as di- or trimethylation of histone 3 on lysine 4 (H3K4me2/me3) should
be enriched in the somatic lineage. Here, we have investigated the deposition of H3K4me3 during
embryogenesis and found that it is more dynamic than anticipated. In the eight-cell stage embryo, H3K4me3
deposition is poor in the germline blastomere, as expected, but surprisingly three somatic blastomeres also
remain poor in H3K4me3. All the other somatic blastomeres show robust deposition of H3K4me3.
Interestingly, the three somatic blastomeres poor in H3K4me3 are descendants of the ﬁrst germline
blastomere, implying an activity that impedes on H3K4me3 deposition in these cells. In contrast, the
deposition of H3K4me2 and H3K27me2/3 is not lineage restricted. Taken together, our data reveal that
H3K4me3 deposition is highly regulated according to the cell lineage involved.Poulin).
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
One of themost fascinating processes of early embryogenesis is the
production of cells with two fundamentally different programs: the
somatic program, which produces cells that are destined to die, and
the germline program responsible for immortality of the species.
Hence, the germline blastomeres face a dilemma at each cell division:
to retain totipotency or to engage the somatic program.
Transcription is highly regulated during early embryogenesis and is
important to establish the distinction between somatic and germline
fates (Mello et al., 1992, 1996; Seydoux and Strome, 1999). Transcrip-
tion transits rapidly from a generally inactive state in all lineages to an
active state speciﬁcally in the somatic lineage (Edgar et al., 1994;
Seydoux and Dunn, 1997; Seydoux and Fire, 1994). In contrast, the
germline lineage remains poor in transcriptional activity.
An important determinant of somatic versus germline lineage is
PIE-1 (Mello et al., 1992). PIE-1 has been shown to segregate in the P
lineage and to disappear when P4 undergoes the ﬁnal symmetric
division (Mello et al., 1996). PIE-1 is an RNA binding protein that can
repress transcription in human cell culture (Zhang et al., 2003).
Deletion of pie-1 causes a dramatic effect on the embryonic lineage;
the P2 lineage loses its germline program and acquires a somatic
program, causing the production of extra intestinal cells (Mello et al.,
1996; Seydoux and Strome, 1999). Therefore, PIE-1 is essential tosuppress the somatic program, possibly by general repression of
transcription.
There is strongevidence that chromatinorganisation is important for
germline development. Work on MES-2, MES-3, and MES-6, the
Polycomb Group-like complex in Caenorhabditis elegans, has shown
that these prevent degeneration of the germline and sterility through
deposition of H3K27me2/3 marks (Bender et al., 2004; Capowski et al.,
1991; Shin andMello, 2003). It was also shown that defects in erasure of
the H3K4me2 marks in the Z2 and Z3 cells compromises germline
immortality (Katz et al., 2009; Schaner et al., 2003; Schaner and Kelly,
2006). Furthermore, inactivation of members of the NuRD (nucleosome
remodelling deacetylase) complex, a chromatin remodelling complex
involved in repression of transcription, causes the ectopic expression of
germline markers in the soma (Unhavaithaya et al., 2002). Therefore,
chromatin organisation is critical to retain the germline program and
also to prevent its expression in the somatic lineage.
Di- or trimethylation marks on H3K4 and H3K27 correlate with
activation of transcription and with repression of transcription,
respectively. Consequently, H3K4me2/3 and H3K27me2/3 are mainly
found at different loci (Cao et al., 2002; Ringrose and Paro, 2004;
Ruthenburg et al., 2007). Despite this anti-correlation, a limited
number of loci have been found co-occupied by H3K4/K27me3marks.
These loci tend to be transcriptionally inactive and to encode for
developmentally regulated transcription factors ready to be activated
at the appropriate time (Azuara et al., 2006; Bernstein et al., 2006).
Methylation marks are deposited and removed by enzymes. A
number of these enzymes are part of the MLL3/SET1 complex in
humans, andwewill refer herein to its C. elegans counterpart as theMLL
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H3K4 and a demethylase activity targeting H3K27 (Agger et al., 2007;
Fisher et al., 2010; Issaeva et al., 2007; Lan et al., 2007; Lee et al., 2007).
The complex can therefore depositmethylmarks onH3K4 (activation of
transcription) and remove methyl marks from H3K27 (relieving
repression of transcription) (Kouzarides, 2007). The MLL complex
requires core components to be effective: WDR-5, ASH-2, and RBBP-5
(Ruthenburg et al., 2007). TheMLL complex can also contain at least two
methyltransferases (SET-16 or SET-2) (Fisher et al., 2010; Simonet et al.,
2007). All these components are conserved in humans.
Here, we investigated the levels of di- and trimethylation at both
H3K4 and H3K27 sites during early embryogenesis. Since these marks
correlate with either activation or repression of transcription, we
anticipated that the germline blastomeres would be poor in
H3K4me2/3 and rich in H3K27me2/3 relatively to the somatic
blastomeres. Interestingly, only the H3K4me3 mark shows levels of
deposition that differ between the different lineages. Indeed, the
germline blastomeres and importantly some of the somatic blasto-
meres remain poor in H3K4me3.We also show usingmutants that the
MLL complex is active at an early stage in both the somatic and
germline blastomeres. Interestingly, both PIE-1 and RBR-2 (a
demethylase targeting H3K4) can affect H3K4me3 levels during
early embryogenesis, but only PIE-1 can prevent H3K4me3 deposition
in the germline blastomeres. Taken together, our data show that the
deposition of the H3K4me3 mark is unique and dynamic compared to
other epigenetic marks investigated here or reported by others.
Results
H3K4me3 in the early embryo and on chromosome X
The C. elegans early embryo is a good model to study how the
somatic lineage differs from the germline lineage, because these
lineages can be tracked in vivo. During early embryogenesis, the
lineage that will generate the gametes is called the P lineage (P0, P1,
P2, P3, and P4). P1-P4 originate from four successive asymmetric cell
divisions that also give rise to four somatic blastomeres (or founder
cells) (Sulston et al., 1983). P4 will later divide symmetrically to
produce the primordial germ cells (PGCs), Z2 and Z3 (Fig. 1A and B).
At this stage, the germline programme is distinct from the somatic
programme (Schaner and Kelly, 2006; Seydoux and Strome, 1999).
It was previously shown that transcription in two- and four-cell
stage embryos is poor (Edgar et al., 1994; Seydoux and Fire, 1994).
Therefore, we investigated whether H3K27me2/me3, the repression-
associated marks, and H3K4me2/me3, the activation-associated
marks, are detectable by immunoﬂuorescence at these stages. We
found that H3K4me2/me3, and H3K27me2/me3 are detectable marks
and appear evenly distributed between the different cells of the
embryos at both two- and four-cell stages (Fig. 1C, data not shown,
and (Schaner et al., 2003)). Therefore, the methylation marks
analysed herein are all present during early embryogenesis, and
each mark is distributed at comparable levels between cells.
TheH3K4me2,H3K27me2, andH3K27me3markshavebeen studied
during post-embryonic germline development. During germline devel-
opment the X chromosome is transcriptionally inactive (Reinke et al.,
2000). Accordingly, the X chromosome is devoid of the H3K4me2mark
(Kelly et al., 2002; Reuben and Lin, 2002), and enriched for both the
H3K27me2/me3 marks (Bender et al., 2004). We predicted thatFig. 1. The H3K4me3mark during early embryonic development. (A) Depiction of the early em
lineages. The AB lineage is entirely formed of somatic cells. The P lineage produces the germ
and D (green)), and the primordial germ cells (Z2 and Z3 (blue)). The latter will generate al
stages of the embryo. In green are the somatic blastomeres, and in green and blue are the ger
of the embryos at two- and four-cell stages. Co-immunostaining for H3K4me3, H3K27me3 an
area at pachytene stage is depleted of the H3K4me3 mark. E) Competition assays using
H3K4me3 antibody is speciﬁc. Two-cell stage embryos are presented, but similar data wereH3K4me3 should adopt a similar localisation as H3K4me2, and indeed
we found a chromosomal area devoid of H3K4me3 (Fig. 1D). This
pattern of deposition suggests that the antibody against H3K4me3
recognised the correct epitope.Nevertheless,weadditionally performed
a peptide competition assay, and show that a peptide trimethylated at
K4 can abrogate theH3K4me3 signal, but a peptide trimethylated atK27
has no effect (Fig. 1E). Taken together, the pattern of deposition, the
competition assays, and other data provided below indicate that this
antibody is speciﬁc to the H3K4me3 mark.
Cell lineage speciﬁc deposition of H3K4me3 at the eight-cell stage
Transcription has been shown to be active at the eight-cell stage
(Edgar et al., 1994). Interestingly, it is at this stage that we observed a
striking difference in H3K4me3 deposition. In contrast, the other
methylation marks (H3K4me2, H3K27me2, and H3K27me3) remained
unchanged. The cells poor inH3K4me3 are the germline blastomere (P3)
and three somatic blastomeres: MS, E, and C (Fig. 2A). The four somatic
blastomeres enriched for H3K4me3 are all AB descendants (Fig. 2A). We
ensured that these four cells are descendants of the AB lineage by
performing co-immunoﬂuorescence with an antibody against GLP-1.
GLP-1 is a Notch homolog found at the membrane and within the
cytoplasm. Importantly, it is expressed only in the AB lineage at the early
stages of embryogenesis (Evans et al., 1994). At four-cell stage only ABa
andABpexpressGLP-1, conﬁrming thatGLP-1 is speciﬁc to theAB lineage
(Fig. 2B). We next analysed the eight-cell stage and found that only four
cells are positive for GLP-1 expression, and that these cells show high
levels of H3K4me3 deposition (Fig. 2C). This indicates that H3K4me3
deposition is high in the AB lineage. We also performed a co-staining
using an antibody against PGL-1, which conﬁrms that levels of H3K4me3
are low in the P3 cell (Supplementary Fig. 1). We next quantiﬁed the
abundance of H3K4me3 relative to H3K27me2 using confocal microsco-
py (Fig. 2D).We analysed 80 cells from ten embryos, and found a 3.3 fold
enrichment in H3K4me3 deposition in the AB descendants compared
with the P1 descendants (Fig. 2E). We have also produced 3D movies to
help visualise these data (Supplementary Fig. 2). Accordingly, similar
results were obtained from another commercially available antibody
against H3K4me3 (Supplementary Fig. 3). Taken together, these data
lead us to conclude that theH3K4me3mark is regulated according to the
cell lineage. Indeed, the somatic blastomeres derived from P1, as well as
P3, are resistant to accumulation of H3K4me3.
Since at eight-cell stagewe have observed four H3K4me3-depeleted
cells, we expected that following an additional cell division, eight cells
(seven somatic cells and P4) would remain depleted of H3K4me3, but
this is not the case. Indeed, only three somatic cells and P4 remain poor
in H3K4me3. This implies that half of the descendants of the four
H3K4me3-depeleted cells are capable of acquiring the H3K4me3 mark
(Fig. 3A). Accordingly, high levels of H3K4me3 are detected in all
somatic cells at thepost-gastrulation stage (Fig. 3B). As expected, Z2 and
Z3, the PGCs, are depleted of the H3K4me3 mark (Fig. 3B) and of the
H3K4me2 mark (Katz et al., 2009; Schaner et al., 2003). Therefore, the
deposition of the H3K4me3 mark is a very dynamic process.
The MLL complex is responsible for acquisition of H3K4me3 during early
embryogenesis
We next addressed whether the deposition of H3K4me3 during
early embryogenesis requires the MLL complex. We used mutants ofbryo lineage. The one cell embryo ﬁrst divides asymmetrically to generate the AB and P
line blastomeres (P1, P2, P3, and P4 (green and blue)), the somatic blastomeres (EMS, C
l the gamete of the adult hermaphrodite. (B) Depiction of the two-, four-, and eight-cell
mline blastomeres. (C) The H3K4me3 and H3K27me2 marks are detected in all the cells
d DNA by DAPI are shown as well as the corresponding DIC picture. (D) A chromosomic
peptides as indicated followed by immunostaining provide further evidence that the
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Fig. 2. H3K4me3 deposition is enriched in the AB lineage. (A) Eight-cell stage embryo showing that H3K4me3 levels are high in the AB lineage, but H3K27me2 levels are similar
regardless of the lineage. The AB lineage is indicated by a dotted line. (B) Co-immunostainings against PGL-1 and H3K4me3 at four-cell stage show that PGL-1 is speciﬁc to the AB
lineage. (C) Co-immunostainings against PGL-1 and H3K4me3 at eight-cell stage show that H3K4me3 and PGL-1 are detected in the same cells, the AB descendants. (D) A confocal
photograph (stacking of multiple slices) shows that H3K4me3 (red) and H3K27me2 (green) only co-localise in half the cells. (E) Quantiﬁcation using confocal images of co-
immunostainings against H3K4me3, H3K27me2 and DAPI. Data are from 80 cells (ten embryos) and four separate experiments. Error bars represent standard error of the mean
(SEM).
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AB
Fig. 3. H3K4me3 deposition is resumed in the somatic lineage. (A) An embryo at 16-cell stage showing that the H3K4me3 mark in the germline blastomere and three somatic
blastomeres is not detectable or very faint (arrows). (B) A post-gastrulation embryo showing that the H3K4me3 mark is undetectable in primordial germline cells, Z2 and Z3, which
express PGL-1 (arrowheads).
231S. Wang et al. / Developmental Biology 355 (2011) 227–238the core components (wdr-5 and rbbp-5) as well as a set-2 mutant.
SET-2 is one of the two methyltransferases targeting H3K4 that have
been shown to be part of the complex (Fisher et al., 2010; Simonet
et al., 2007). Initially, we performed co-immunoﬂuorescence at two-,
and four-cell stages in the wdr-5 mutant. This mutant has already
been shown to be impaired in deposition of H3K4me3 (Fisher et al.,
2010; Simonet et al., 2007), but not at early stages of embryonic
development. We started our analysis at the two-cell stage, and could
still detect H3K4me3 deposition, though the signal appeared weaker
than in wild type worms (Fig. 4A). However, at four-cell stage, we
were unable to detect the H3K4me3 mark (Fig. 4B). Noteworthy, we
found no defect in levels of deposition of H3K27me2 (Figs. 4A and B)
or of H3K27me3 (data not shown).
Additionally, we analysed the eight-cell stage and found that the
H3K4me3 mark is undetectable in wdr-5, rbbp-5, and set-2 mutants
compared toN2 (Fig. 5A).Weperformed the samesystematic analysis at
post-gastrulation stage. We obtained the same result with wdr-5 andrbbp-5mutants, but surprisingly the set-2mutant showed a detectable
albeit low level of H3K4me3 (Fig. 5B). To ensure that these observations
based on immunoﬂuorescence are not due to masking of speciﬁc
epitopes,weperformedwesternblot analysis usingextracts fromwdr-5,
rbbp-5, and ash-2 mutants and compared levels of H3K4me3 to wild
type embryoextracts.We found that in all themutant cases,H3K4me3 is
undetectable, which is consistent with our immunoﬂuorescence data
(Fig. 5C).We conclude that theMLL complex is required for appropriate
deposition of H3K4me3 during embryogenesis.
H3K4me3 deposition remains low in germline blastomeres from rbr-2
mutants
Our observations are consistent with a dynamic and lineage
speciﬁc regulation of H3K4me3 deposition during embryogenesis, in
which theMLL complexmust be playing an important role in cells rich
in H3K4me3. However, poor deposition of H3K4me3 could be
A B
C D
Fig. 4. WDR-5 is required to generate the H3K4me3 mark. (A) Two-cell stage N2 embryo in which the H3K4me3 and H3K27me2 marks can be detected. (B) Two-cell stage wdr-5
embryo in which the H3K4me3 mark appears diminished, and in which the H3K27me2 marks is not affected. (C) Four-cell stage N2 embryo in which the H3K4me3 and H3K27me2
marks can be detected. (D) Four-cell stage wdr-5 embryo showing that the H3K4me3 mark is now undetectable, but H3K27me2 deposition is unaffected.
232 S. Wang et al. / Developmental Biology 355 (2011) 227–238explained by both reduced MLL activity and increased demethylase
activity. Two types of demethylases targeting H3K4 have been
described in C. elegans: LSD1-like and RBR-2 (Christensen et al.,2007; Cloos et al., 2008; Greer et al., 2010; Katz et al., 2009). The LSD1
ortholog, SPR-5, can demethylate H3K4me2/me1 and has been shown
to be active in the PGCs (Katz et al., 2009). On the other hand, RBR-2
AB
C
Fig. 5.Mutants of theMLL complex show reduced levels of H3K4me3. (A) The coreMLL complex, rbbp-5, andwdr-5, as well as themethyltransferase set-2, are required for deposition of
H3K4me3 at the eight-cell stage of embryogenesis. (B) The core MLL complex, rbbp-5, andwdr-5, as well as the methyltransferase set-2, are required for deposition of H3K4me3 at post
gastrulation. (C) Western blot analysis against H3K4me3 using different antibodies shows that embryonic extracts from wdr-5, rbbp-5, and ash-2 have reduced levels of H3K4me3.
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since it can target H3K4me3 (Christensen et al., 2007). To test
whether demethylation by RBR-2 contributes to the H3K4me3
pattern of deposition, we used an rbr-2 mutant, and analysed its
effect at multiple stages, including the eight-cell stage. At this stage,
we found that the rbr-2 embryos deposit H3K4me3 in a pattern
similar to wild type animals (Fig. 6A, eight-cell stage). Importantly, we
could not detect H3K4me3 deposition in the P4 or later in Z2 and Z3,
the PGCs (Fig. 6A, P4 and Z2-Z3). However, when we compared the
H3K4me3 levels between the rbr-2 mutant and wild type, we
observed an enrichment of H3K4me3 in the somatic cells (Fig. 6B).
We quantiﬁed this observation using western blot analysis, and
detected about four times the level of H3K4me3 in rbr-2 embryos
compared with wild type, with no effect on H3K27me3 deposition
(Fig. 6C). Therefore, RBR-2 is not involved in preventing H3K4me3A
Fig. 6. H3K4me3 deposition remains low in germline blastomeres in rbr-2mutants. (A) H3K4me3
between rbr-2 and N2 embryos suggests an elevated deposition of H3K4me3 in rbr-2 embryos. (C
deposition of H3K4me3 in rbr-2 embryos. K4_r indicates blotting using the rabbit anti-H3K4me3 (a
rabbit anti-H3.deposition in the P lineage, but could play a role in regulating somatic
deposition of H3K4me3.
Absence of PIE-1 activates deposition of H3K4me3 in the P lineage
PIE-1 has been shown to be critical to maintain the germline fate
through repression of transcription in the P lineage (Mello et al., 1992;
Mello et al., 1996; Seydoux and Strome, 1999; Zhang et al., 2003).
Herein, we have shown that deposition of H3K4me3, an activation
mark, is low in the P lineage. Hence, we tested whether the absence of
PIE-1, a repressor of transcription, could promote the deposition of
H3K4me3 in the P lineage, and the somatic descendants of P1. Using a
pie-1mutant and performing similar analysis as presented above, we
did not observe an effect on the deposition of H3K4me3 at two- and
four-cell stages (Figs. 7AB). However, we found that at eight-cellB
C
deposition is not affected in germline blastomeres of rbr-2mutant embryos. (B) Comparison
) Comparison between rbr-2 and N2 embryos using western blot analysis shows an elevated
b8580), H3K4_m, themouse anti-H3K4me3(ab1012), K27 a rabbit anti-H3K27me3, andH3 a
A B
DC
Fig. 7. H3K4me3 deposition is activated in germline blastomeres in pie-1 mutants. (A and B) Immunostainings at two- and four-cell stages with pie-1 embryos showing that
H3K4me3 deposition appears normal. (C) An eight-cell stage pie-1 embryo showing that the H3K4me3 mark can be detected in all cells, including P3. (D) A later stage of a pie-1
embryo showing that H3K4me3 is present in P4.
235S. Wang et al. / Developmental Biology 355 (2011) 227–238stage, the embryos depleted of PIE-1 acquire the H3K4me3mark in P3
and in the somatic cells in which H3K4me3 is normally poor (Fig. 7C).
Strikingly, even at later stages of development, we observeddeposition of H3K4me3 in P4 (Fig. 7D). Therefore PIE-1 is critical to
prevent accumulation of H3K4me3 in germline blastomeres and in the
somatic descendants of P1.
236 S. Wang et al. / Developmental Biology 355 (2011) 227–238H3K4me3 deposition is robust in the germline
The effect that the wdr-5 mutant has on levels of H3K4me3 in
embryo is striking (Fig. 5). But surprisingly, previous studies have
shown that L4 or adults express levels of H3K4me3 that can easily be
detected by Westerns blot analysis (Fisher et al., 2010; Simonet et al.,
2007). One explanation (other than the sensitivity of themethods) for
these results is that the germ cells of the wdr-5 animals maintain
robust deposition of H3K4me3. Hence, we tested this possibility by
performing immunostaining in the gonads of wdr-5 mutants. We
found that in the wild type gonads, the H3K4me3 pattern of
deposition is dynamic. It is at a lower level in the mitotic zone, but
at a higher level in the other zones (Fig. 8A). In contrast, the
differential distribution of the H3K27me2 modiﬁcation is similar
between the different zones, in particular if the DAPI signal is taken
into consideration (Fig. 8A). Importantly, in the wdr-5 gonads, the
H3K4me3 mark is detectable, but its deposition pattern has changed
(Fig. 8B). It appears that the zone normally low in H3K4me3 levels is
extended in wdr-5 mutants (Fig. 8B). This may explain the source of
H3K4me3 detected by western blot analysis in wdr-5 animals (Fisher
et al., 2010; Simonet et al., 2007), and also suggests that H3K4me3
deposition in the germline is more robust than in the embryo.A
Fig. 8. Germline deposition of H3K4me3 in N2 and a wdr-5mutant. (A) Wild type germlines
H3K27me2mark is evenly distributed relative to DAPI staining. (B) Thewdr-5mutant can stilImportantly, our data from embryos and the germline imply that
embryonic viability and fertility could be affected in mutants of the
core MLL complex. Hence, we assessed these functions in the wdr-5,
rbbp-5 and ash-2 mutants. We found that embryonic viability and
fertility in all mutants are compromised at both 20 °C and 25 °C. But
surprisingly, these functions are affected differentially. For example,
the wdr-5 mutant produces 45% embryonic lethality at 25 °C
compared with 16% for rbbp-5 (pb0.005) and 0% for ash-2
(pb0.00005) (Table 1). On the other hand, brood size is more affected
in ash-2 (6 progeny, pb0.0005) or rbbp-5 (19 progeny, pb0.001) than
in wdr-5 (54 progeny) (Table 1). Perhaps this is an indication that the
MLL core complex can associate with different partners according to
the site of expression. Despite this extra layer of complexity, our data
support the view that proper embryonic development and fertility
requires deposition of methyl groups on H3K4.
Discussion
Transcriptional activity during early embryogenesis is poor in the
germline blastomeres, but processive in the somatic blastomeres
(Edgar et al., 1994; Schaner and Kelly, 2006; Schaner et al., 2003;
Seydoux and Dunn, 1997; Seydoux and Fire, 1994; Seydoux andB
showing that the deposition of the H3K4me3 mark is low level in the mitotic zone. The
l deposit H3K4me3 in the germline, but the zone in which the levels are low is extended.
Table 1
Embryonic viability and fertility analysis of mutants of the MLL core complex. P values:
*pb0.01, **pb0.005, ***pb0.0001, ****pb0.000001.
Genotypes, temp % emb. leth. aver. brood size
N2, 20 °C 0 204
N2, 25 °C 0.5 149
wdr-5, 20 °C 4** 111**
wdr-5, 25 °C 45*** 54***
rbbp-5, 20 °C 2 44***
rbbp-5, 25 °C 16 19****
ash-2, 20 °C 5* 38****
ash-2, 25 °C 0 6****
237S. Wang et al. / Developmental Biology 355 (2011) 227–238Strome, 1999). Previous studies have investigated the deposition of
methylation and acetylation marks during early embryogenesis and
found that H3K4me2 is actively removed from the PGCs later during
embryogenesis (N26-cell stage). Prior to this stage, the levels of
H3K4me2 (and other marks) remain equivalent in all cells of the early
embryo (Katz et al., 2009; Schaner and Kelly, 2006; Schaner et al.,
2003). Similarly, we found that H3K4me2 and H3K27me2/me3 levels
remain equivalent prior to the generation of PGCs. However, we
uncovered that the H3K4me3 mark has a unique distribution during
embryogenesis. Indeed, some of the somatic blastomeres and the
germline blastomeres fail to accumulate the H3K4me3 marks.
Interestingly, this characteristic is regulated by PIE-1. Therefore, it is
likely that deposition of the H3K4me3 mark is important for the
development of the germline blastomeres.
Prior to this study there was no evidence that the chromatin
architecture of germline blastomeres could be different from somatic
blastomeres. Indeed, most data indicated that, at least at a superﬁcial
level, both types of blastomeres were equivalent in deposition of
numerous metylation and acetylation marks thereby implying that
their chromatin architecture was similar. Here, we provide new
insights into a possible role that a speciﬁc mark (H3K4me3) may play
to ensure that the chromatin architecture adopted in the germline
blastomeres is in accordancewith its transcriptional status. Consistent
with this role, we found that in absence of PIE-1, deposition of
H3K4me3 is restored in germline blastomeres, and that the
differential deposition between somatic blastomeres at the eight-
cell stage is abolished. Therefore, these data imply interplay between
the general transcriptional repressor PIE-1 and the chromatin
architecture of the germline blastomeres.
The observation that speciﬁc somatic blastomeres fail to accumu-
late the H3K4me3 mark was unexpected. Interestingly, the somatic
blastomeres “resistant” to the deposition of the third methylation
mark on H3K4 are derived from the germline blastomere P1. Hence,
we would like to raise the possibility that the P1 germline blastomere
produces an activity that prevents the MLL complex to deposit the
third methylation mark on H3K4 or/and that it stimulates its removal
by a still undiscovered demethylase. However, this putative activity
from P1 may not affect directly the MLL complex or the demethylase,
but could affect the deposition or removal of other marks on the
chromatin leading to the effect characterised herein. Our data appear
to rule out RBR-2 as a potential demethylase, since it is not required to
maintain the H3K4me3 deposition pattern at the eight-cell stage
(Fig. 6). Finally, considering that the germline blastomere is a type of
stem cell, our ﬁndingsmay provide new insights into how totipotency
(and perhaps also pluripotency) can be maintained by controlling the
deposition of the third methyl mark on H3K4.
Materials and methods
Strains and general maintenance
Strains were maintained as previously described (Brenner, 1974).
The strains used in this study were: wdr-5(ok1417), set-2 (ok952),rbbp-5(tm3463), ash-2(tm1905), rbr-2(tm1231), pie-1(zu154) unc-25
(e156)/qC1 dpy-19(e1259) glp-1(q339) and Bristol N2 as wild type.
Co-immunoﬂuorescence
Immunoﬂuorescence by freeze crack was performed on polylysine
treated slides at 0.3%. Slides treated by application of 75 μl of
polylysine 0.3%, dried 10 min at 70 °C, quickly rinsed in distilled
water and excess liquid wiped off. The slides were 3×14 mm printed
wells from Fisher Scientiﬁc LTD UK. About 30 mothers were placed in
a well with a drop of M9 buffer, to wash off bacteria. These mothers
were transferred into a 5-6 μl drop of M9 onto the polylysine treated
well using an eyelash. A cover slip (22 mm×50 mm) was applied at a
right angle and the slide placed at −80 °C for at least 20 min. The
cover slip was then promptly removed and embryosmethanol ﬁxed at
−20 °C for 10 min, washed 5 min in PBS, and then followed by two
washes in PBS-tween 0.2%. Primary antibodywas incubated overnight
at 4 °C in a humid chamber. Washes performed as described above.
Secondary antibody was incubated 2 h at 37 °C. Washes performed as
described above. Mowiol was applied to preserve ﬂuorescence.
Primary antibodies used: anti-H3K4me3 (Abcam, ab1012 and
ab8580), anti-H3K4me2 (Abcam, ab32356), anti-H3K27me3 (Milli-
pore/Upstate, 07-449), anti-H3K27me2 (Millipore/Upstate, 07–452),
and anti-H3 (Abcam, 1791). The secondary antibodies used are from
Jackson ImmunoResearch: DyLight 594 AfﬁniPure Goat Anti-Mouse
IgG (H+L) (cat.115-515-146) and DyLight 488 AfﬁniPure Goat Anti-
Rabbit IgG (H+L) (cat.111-485-144). Our controls performed
without primary antibody show that these secondary antibodies do
not produce signiﬁcant background (data not shown).
Image processing
Confocal images were analysed using imageJ software. Individual
slices were selected for every cell to discriminate between over-
lapping cells. We used eight-cell stage embryos in which AB
descendants are distinctive from P1 descendants, i.e. the AB cells
enter mitosis faster than the P1 linage. We expressed the results as a
ratio of the H3K4me3 signal over the H3K27me2 signal for each cells.
Peptide competition assays
Peptides were preincubated in three fold excess with the anti-
H3K4me3 (ab1012) at room temperature for 30 min prior to
immunostainings. Immunostainings were performed as described
above. The peptides used were produced by Abcam (ab1432,
H3K4me3) and (ab1782, H3K27me3).
Western blot analysis
Western blot analysis was performed as described in (Fisher et al.,
2010) with a fewmodiﬁcations. Brieﬂy, embryo protein extracts were
prepared by bleaching young mothers followed by washing the
embryos four times with M9 buffer. A minimum volume of 20 μl
pelleted embryos was collected for each protein sample, boiled in
Laemmli buffer containing 100 mM DTT and sonicated.
Embryonic and fertility analysis
To calculate brood size and embryonic lethality ten clones per
strain were transferred onto fresh plates every day until the worms
had ﬁnished laying. The number of embryos and progeny were
counted each day. Embryos are considered dead if they did not hatch
after more than 24 h and appeared grossly abnormal.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2011.04.010.
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